Shineco, Inc. ("Shineco" or the "Company"; Nasdaq: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural produce, hemp products, and various health and well-being focused plant-based products in China, announced today that the Company received a letter from Nasdaq Listing Qualifications Staff (“Nasdaq”) that the Company has been granted an additional 180-day grace period or until June 20, 2020 (“Expiration Date”) to regain compliance with the minimum $1.00 bid price per share Listing Rule (the “Rule”).

The CEO of Shineco, Inc. (NASDAQ:TYHT) is Yuying Zhang. This report will, first, examine the CEO compensation levels...

Shineco, Inc. ("Shineco" or the "Company"; NASDAQ: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural produce, hemp products, and various health and well-being focused plant-based products in China, announced today that its wholly owned subsidiary Tenjove NewHemp Biotech Co., Ltd. ("TNB") has achieved progress in its industrial product system which focuses on cannabidiol development (“CBD”). The Company has achieved good progress with hemp planting, product research and development, and technical supports. Both parties spent 3 years jointly cultivating Xinma No.1 (M11), a high-quality industrial hemp seed.

BEIJING, Sept. 27, 2019 -- Shineco, Inc. ("Shineco" or the "Company"; NASDAQ: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural produce,.

Shineco, Inc. ("Shineco" or the "Company"; Nasdaq: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural produce, hemp products, and various health and well-being focused plant-based products in China, announced today that the Company, through its subsidiary Shineco China Hemp Technology Co., Ltd. (“SCHT”), has entered into a strategic cooperation agreement (the “Agreement”) with Pacific Islands Trade and Investment Commission (“PITIC”) to explore business opportunities of Industrial Hemp in Pacific Island areas.

Shineco, Inc. ("Shineco" or the "Company"; NASDAQ: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural produce, hemp products, and various health and well-being focused plant-based products in China, announced today that it signed a RMB70 million (approximately USD10 million) industry hemp fiber preliminary processing sales contract (the “Contract”) with Chengongliao (Beijing) Science & Trade Co., Ltd. (“CSTC”), an enterprise focusing on hemp processing in China.

NASDAQ: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural produce, specialized textiles, and various health and well-being focused plant-based products in China, announced today that the Company entered into a strategic cooperation agreement (the “Agreement”) with Shanxi Yushe County Xunmengyuan Construction Management Co., Ltd. (“SYCX”) on July 29, 2019 to jointly construct China’s first Industrial Hemp Technology Living Museum (the “Museum”). Pursuant to the Agreement, the Company plans to acquire 51% of SYCX to establish an industrial hemp museum in Shanxi province of China.

Shineco, Inc. ("Shineco" or the "Company"; NASDAQ: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural produce, hemp products, and various health and well-being focused plant-based products in China, announced today that the Company, through its subsidiary Shineco China Hemp Technology Co., Ltd. (“SCHT”), has award an certificate (the “Certificate”) from Trade & Association (Singapore) (“TIAS”) on November 29, 2019 to jointly establish industry hemp comprehensive utilization park (the “Park”) in China. The Certificate is effective for 3 years.

Shineco, Inc. ("Shineco" or the "Company"; NASDAQ: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural produce, specialized textiles, and various health and well-being focused plant-based products in China, announced today that the Company, through its subsidiary Shineco China Hemp Technology Co., Ltd.(“SCHT”), has entered into a 500,000 mu (approximately 82,348 acres) hemp fiber preliminary processing sales framework contract (the “Contract”) with Shanxi Oasis Textile Co., Ltd.(“Oasis”), one of the largest enterprises in China that produces textiles of hemp [and is the National Textile Industry Hemp Product Development Base.

NASDAQ: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural produce, specialized textiles, and various health and well-being focused plant-based products in China, announced today that the Company expects to launch hemp based cosmeceutical products on the Chinese market in August 2019 under its brand, LABEE. The Company entered into a strategic cooperation agreement (the “Agreement”) with Heilongjiang Harbin Beima Technology Development Co., Ltd.(“HBTD”) on July 19, 2019 for industrial hemp related research, production, and sales including cosmeceuticals, pharmaceuticals, health care products, etc.

Shineco, Inc. ("Shineco" or the "Company"; NASDAQ: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural produce, hemp products, and various health and well-being focused plant-based products in China, announced today that Mr. Yuying Zhang, Chairman and Chief Executive Officer of Shineco, has reached a consensus on cooperation with Vice Mayor Zhang Jianchun of Wuchang municipal government of Heilongjiang Province (the Government) regarding Shineco’s industry hemp development plan in Heilongjiang Province (the “Plan”).

Anyone researching Shineco, Inc. (NASDAQ:TYHT) might want to consider the historical volatility of the share price...

The last full week of the year, and decade, came with relatively few developments. We started off with some sad news, as we learned psychedelic pioneer and spiritual teacher Ram Dass,  born Richard Alpert, ...

Shineco, Inc. ("Shineco" or the "Company"; NASDAQ: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural produce, hemp products, and various health and well-being focused plant-based products in China, announced today the Company, through its wholly owned subsidiary Beijing Tenjove NewHemp Biotech Co., Ltd. ("TNB"), has entered into a strategic cooperation agreement (the “Agreement”) with Wuchang Municipal Government of Heilongjiang Province (the “Government”) on December 18, 2019.

Yuying Zhang is the CEO of Shineco, Inc. (NASDAQ:TYHT). This analysis aims first to contrast CEO compensation with...

Anyone researching Shineco, Inc. (NASDAQ:TYHT) might want to consider the historical volatility of the share price...

NASDAQ: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural produce, specialized textiles, and various health and well-being focused plant-based products in China, announced today that it entered into a strategic cooperation (the “Agreement”) with Shanxi Hongtian Jiali Agricultural Technology Co., Ltd. (“Hongtian Jiali”) on July 29, 2019. Hongtian Jiali is a leading industrial hemp agriculture technology company in Shanxi province of China. Hongtian Jiali, located in Jinzhong City of Shanxi province, processes and sells industrial hemp oil, industrial hemp protein powder, industrial hemp oligopeptides and other products.

Re-elected Mr. Yuying Zhang as the Chairman of the Board of Company to hold office until the next annual general meeting. Elected Mr. Baolin Li as the Vice Chairman of the Board of Company to hold office until the next annual general meeting.

The simplest way to invest in stocks is to buy exchange traded funds. But investors can boost returns by picking...

Shineco, Inc. ("Shineco" or the "Company"; Nasdaq: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural produce, specialized textiles, and various health and well-being focused plant-based products in China, announced today that it has regained compliance with Nasdaq’s continued listing requirement and rules with respect to annual meeting of shareholders. On July 1, 2019, the Company received a written notification from the Nasdaq Listing Qualifications Staff indicating that the Company did not comply with the annual meeting requirement for continued listing on The Nasdaq Capital Market set forth in Listing Rule 5620 (the “Rule”).